Analgesic nephropathy and the renal concentrating mechanism
Burry, A.; Cross, R.; Axelsen, R.
Pathology Annual 12 Pt 2: 1-31
1977
ISSN/ISBN: 0079-0184 PMID: 341056 Document Number: 120557
Document emailed within 1 workday
Related Documents
Steele, T.W.; Edwards, K.D. 1971: Analgesic nephropathy. Changes in various parameters of renal function following cessation of analgesic abuse Medical Journal of Australia 1(4): 181-187Jamison, R.J.; Henle, F.G. 1987: The renal concentrating mechanism Kidney International. Suppl 21: S43-S50
de Rouffignac, C.; Elalouf, J.M. 1983: Effects of calcitonin on the renal concentrating mechanism American Journal of Physiology 245(4): F506-F511
Vítko, S.; Prát, V.; Matousovic, K.; Dráb, K.; Horcicková, M. 1984: Analgesic nephropathy. II. Analgesic nephropathy and analgesic syndrome, diagnosis and treatment Casopis Lekaru Ceskych 123(35): 1079-1082
Nakanishi, T.; Takamitsu, Y. 1996: Renal concentrating defect and organic osmolytes. Paradoxical changes of renal medullary taurine contents in potassium-depleted rats Advances in Experimental Medicine and Biology 403: 193-201
Thieler, H.; Schäfer, W. 1988: The diagnosis of analgesic nephropathy Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 43(17): 499-504
Gordon, J.A.; Dillingham, M.A.; Guggenheim, S.J.; Grossfeld, P.D.; Anderson, R.J. 1983: The renal concentrating defect after gentamicin administration in the rat Journal of Laboratory and Clinical Medicine 101(6): 903-910
Regester, R.F. 1978: Analgesic nephropathy: an increasing problem Journal of the Tennessee Medical Association 71(10): 741-744
Vanherweghem, J.L.; Even-Adin, D. 1982: Epidemiology of analgesic nephropathy in Belgium Clinical Nephrology 17(3): 129-133
Thomas, C.; Sortur, S.V.; Mehta, N.M.; Nag, N.K. 1974: Analgesic nephropathy (a case report) Journal of the Association of Physicians of India 22(9): 693-695
Anandan, J.V.; Matzke, G.R. 1981: Nephropathy as a hazard of analgesic abuse American Journal of Hospital Pharmacy 38(10): 1536-1539
Murray, R.M. 1973: The geographical distribution of analgesic nephropathy Health Bulletin 31(1): 32-34
Kojima, H.; Ohi, H.; Miyaji, H.; Seki, M.; Fujita, T.; Hatano, M. 1987: Localization of C3d in renal tissues of patients with membranous nephropathy and IgA nephropathy Nihon Jinzo Gakkai Shi 29(9): 1161-1165
Scheler, F.; Schoel, G. 1986: Abuse of analgesics with special reference to analgesic nephropathy Der Internist 27(12): 770-777
Kantachuvesiri, S.; Kaojarern, S.; Kitayaporn, D.; Phanichphant, S.; Sumethkul, V.; Wananukul, W.; Pongskul, C.; Arkaravichien, W.; Jankriengkri, S.; Chanchairujira, T. 1996: Risk factors between analgesic use and chronic nephropathy in Thailand Southeast Asian Journal of Tropical Medicine and Public Health 27(2): 350-355
1978: Questions and replies: renal mechanisms for urinary concentrating and diluting processes American journal of physiology 235(1): F1-11
Jaeger, P.; Burckhardt, P.; Wauters, J.P.; Trechsel, U.; Bonjour, J.P. 1982: Particularly severe calcium metabolic disorder in nephropathy from analgesic abuse Schweizerische Medizinische Wochenschrift 112(49): 1791-1794
Levison, S.P.; Levison, M.E. 1976: Effect of indomethacin and sodium meclofenamate on the renal concentrating defect in experimental enterococcal pyelonephritis in rats Journal of Laboratory and Clinical Medicine 88(6): 958-964
Sonoda, H.; Omote, K. 1996: Analgesic mechanism of ketamine Masui. Japanese Journal of Anesthesiology 45(6): 689-697
Shimoji, K. 1979: Endogenous morphine-like substances and their analgesic mechanism (1) Masui. Japanese Journal of Anesthesiology 28(3): 223-234